A versatile post-polymerization modification method for polyglutamic acid: synthesis of orthogonal reactive polyglutamates and their use in "click chemistry"

被引:37
作者
Barz, Matthias [1 ,2 ]
Duro-Castano, Aroa [1 ]
Vicent, Maria J. [1 ]
机构
[1] Ctr Invest Principe Felipe, Polymer Therapeut Lab, Valencia 46012, Spain
[2] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany
关键词
4-(4,6-DIMETHOXY-1,3,5-TRIAZIN-2-YL)-4-METHYL-MORPHOLINIUM CHLORIDE; GROWING APPLICATIONS; THERAPEUTICS; DMTMM; BIOCONJUGATION; CONJUGATION; PACLITAXEL; LIGATION; PROTEINS; TAXANE;
D O I
10.1039/c3py00189j
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In this article we describe a versatile methodology for the synthesis of polyglutamic acid (PGA) derivatives bearing orthogonal reactive sites. The reactive groups enable selective conjugation chemistry by copper catalyzed azide-alkyne coupling (CuAAC). PGA was derived in aqueous media as well as in organic media using 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride (DMTTM) salts. The spectra of attached chemical moieties ranges from simple PEGylation with 2,5,8,11,14,17,20-heptaoxadocosan-22-amine (mEG(6)NH2) to the incorporation of propargylamine, 11-azido-3,6,9-trioxaundecan-1-amine (NH2-EG(2)N-3), and 20-azido-3,6,9,12,15,18-hexaoxaicosan-1-amine (NH2-EG(6)N-3). Herein, it is demonstrated that the degree of functionalization can be easily controlled within this one pot reaction. Additionally, we report conditions for the CuAAC with various PGA derivatives, which can be employed for site-specific conjugation of either hydrophilic or hydrophobic compounds.
引用
收藏
页码:2989 / 2994
页数:6
相关论文
共 45 条
[1]   Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure-property relationships to better defined therapeutics [J].
Barz, Matthias ;
Luxenhofer, Robert ;
Zentel, Rudolf ;
Vicent, Maria J. .
POLYMER CHEMISTRY, 2011, 2 (09) :1900-1918
[2]   Modulating Catalytic Activity of Polymer-Based CuAAC "click" Reactions [J].
Bell, Craig A. ;
Jia, Zhongfan ;
Perrier, Sebastien ;
Monteiro, Michael J. .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 2011, 49 (21) :4539-4548
[3]   Enzymatically Catalyzed HES conjugation Using Microbial Transglutaminase: Proof of Feasibility [J].
Besheer, Ahmed ;
Hertel, Thomas C. ;
Kressler, Joerg ;
Maeder, Karsten ;
Pietzsch, Markus .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (11) :4420-4428
[4]   Polymer-drug conjugates as nano-sized medicines [J].
Canal, Fabiana ;
Sanchis, Joaquin ;
Vicent, Maria J. .
CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 (06) :894-900
[5]  
Conejos-Sanchez I., 2013, POLYM CHEM IN PRESS
[6]  
Cortes J, 2012, ANN ONCOL, V23, P43
[7]   Functional polymers as therapeutic agents: Concept to market place [J].
Dhal, Pradeep K. ;
Polomoscanik, Steven C. ;
Avila, Louis Z. ;
Holmes-Farley, S. Randall ;
Miller, Robert J. .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (13) :1121-1130
[8]   Immunological properties of engineered nanomaterials [J].
Dobrovolskaia, Marina A. ;
Mcneil, Scott E. .
NATURE NANOTECHNOLOGY, 2007, 2 (08) :469-478
[9]   Polymer therapeutics-prospects for 21st century: The end of the beginning [J].
Duncan, Ruth ;
Vicent, Maria J. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :60-70
[10]   Nanomedicine(s) under the Microscope [J].
Duncan, Ruth ;
Gaspar, Rogerio .
MOLECULAR PHARMACEUTICS, 2011, 8 (06) :2101-2141